H. Badrane, C. Bahloul, P. Perrin, and N. Tordo, Evidence of Two Lyssavirus Phylogroups with Distinct Pathogenicity and Immunogenicity, Journal of Virology, vol.75, issue.7, pp.3268-3276, 2001.
DOI : 10.1128/JVI.75.7.3268-3276.2001

I. Kuzmin, G. Hughes, A. Botvinkin, L. Orciari, and C. Rupprecht, Phylogenetic relationships of Irkut and West Caucasian bat viruses within the Lyssavirus genus and suggested quantitative criteria based on the N gene sequence for lyssavirus genotype definition, Virus Research, vol.111, issue.1, pp.28-43, 2005.
DOI : 10.1016/j.virusres.2005.03.008

I. Kuzmin, X. Wu, N. Tordo, and C. Rupprecht, Complete genomes of Aravan, Khujand, Irkut and West Caucasian bat viruses, with special attention to the polymerase gene and non-coding regions, Virus Research, vol.136, issue.1-2, pp.81-90, 2008.
DOI : 10.1016/j.virusres.2008.04.021

URL : https://hal.archives-ouvertes.fr/pasteur-00365711

D. Knobel, S. Cleaveland, P. Coleman, E. Fèvre, and M. Meltzer, Re-evaluating the burden of rabies in Africa and Asia, Bull World Health Organ, vol.83, pp.360-368, 2005.

A. Fooks, Rabies remains a 'neglected disease, Eurosurveillance, vol.10, pp.211-212, 2005.

M. Mallewa, A. Fooks, D. Banda, P. Chikungwa, and L. Mankhambo, Rabies Encephalitis in Malaria-Endemic Area, Malawi, Africa, Emerging Infectious Diseases, vol.13, issue.1, pp.136-139, 2007.
DOI : 10.3201/eid1301.060810

X. Tang, M. Luo, S. Zhang, A. Fooks, and R. Hu, Pivotal Role of Dogs in Rabies Transmission, China, Emerging Infectious Diseases, vol.11, issue.12, pp.1970-1972, 2005.
DOI : 10.3201/eid1112.050271

B. Dietzschold, M. Kao, Y. Zheng, Z. Chen, and G. Maul, Delineation of putative mechanisms involved in antibody-mediated clearance of rabies virus from the central nervous system., Proceedings of the National Academy of Sciences, vol.89, issue.15, pp.7252-7256, 1992.
DOI : 10.1073/pnas.89.15.7252

M. Lafon, T. Wiktor, and R. Macfarlan, Antigenic Sites on the CVS Rabies Virus Glycoprotein: Analysis with Monoclonal Antibodies, Journal of General Virology, vol.64, issue.4, pp.843-851, 1983.
DOI : 10.1099/0022-1317-64-4-843

C. Schumacher, B. Dietzschold, H. Ertl, H. Niu, and C. Rupprecht, Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies., Journal of Clinical Investigation, vol.84, issue.3, pp.971-975, 1989.
DOI : 10.1172/JCI114260

B. Dietzschold, Monoclonal Antibodies in Rabies Therapy, Clinical Immunotherapeutics, vol.66, issue.Suppl. 4, pp.245-249, 1994.
DOI : 10.1007/BF03259250

H. Wilde, P. Chomchey, P. Punyaratabandhu, P. Phanupak, and S. Chutivongse, Purified equine rabies immune globulin: a safe and affordable alternative to human rabies immune globulin, Bull World Health Organ, vol.67, pp.731-736, 1989.

H. Wilde, P. Chomchey, S. Prakongsri, P. Puyaratabandhu, and S. Chutivongse, Adverse effects of equine rabies immune globulin, Vaccine, vol.7, issue.1, pp.10-11, 1989.
DOI : 10.1016/0264-410X(89)90003-0

J. Champion, R. Kean, C. Rupprecht, A. Notkins, and H. Koprowski, The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure, Journal of Immunological Methods, vol.235, issue.1-2, pp.81-90, 2000.
DOI : 10.1016/S0022-1759(99)00223-9

C. Macek, Monoclonal antibodies: key to a revolution in clinical medicine, JAMA: The Journal of the American Medical Association, vol.247, issue.18, pp.2463-2470, 1982.
DOI : 10.1001/jama.1982.03320430003001

C. Chan, A. Chan, B. Hanson, and E. Ooi, The use of antibodies in the treatment of infectious diseases, Singapore Med J, vol.50, pp.663-672, 2009.

S. Siberil and J. Teillaud, Future prospects in antibody engineering and therapy Novel Technologies and Therapeutic Use, pp.199-205, 2004.

B. Dietzschold, M. Gore, P. Casali, Y. Ueki, and C. Rupprecht, Biological characterization of human monoclonal antibodies to rabies virus, J Virol, vol.64, pp.3087-3090, 1990.

N. Dorfman, B. Dietzschold, W. Kajiyama, Z. Fu, and H. Koprowski, Development of Human Monoclonal Antibodies to Rabies, Hybridoma, vol.13, issue.5, pp.397-402, 1994.
DOI : 10.1089/hyb.1994.13.397

R. Rando and A. Notkins, Production of Human Monoclonal Antibodies Against Rabies Virus, Curr Top Microbiol Immunol, vol.187, pp.195-205, 1994.
DOI : 10.1007/978-3-642-78490-3_11

C. Hanlon, C. Demattos, C. Demattos, M. Niezgoda, and D. Hooper, Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis, Vaccine, vol.19, issue.28-29, pp.3834-3842, 2001.
DOI : 10.1016/S0264-410X(01)00135-9

S. Sloan, C. Hanlon, W. Weldon, M. Niezgoda, and J. Blanton, Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates, Vaccine, vol.25, issue.15, pp.2800-2810, 2007.
DOI : 10.1016/j.vaccine.2006.12.031

K. Muhamuda, S. Madhusudana, and V. Ravi, Use of Neutralizing Murine Monoclonal Antibodies to Rabies Glycoprotein in Passive Immunotherapy Against Rabies, Human Vaccines, vol.3, issue.5, pp.192-195, 2007.
DOI : 10.4161/hv.3.5.4386

C. Jallet, Y. Jacob, C. Bahloul, A. Drings, and E. Desmezières, Chimeric lyssavirus glycoproteins with increased immunological potential, J Virol, vol.73, pp.225-233, 1999.

A. Bakker, W. Marissen, R. Kramer, A. Rice, and W. Weldon, Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In Vitro Escape Mutants, Journal of Virology, vol.79, issue.14, pp.9062-9068, 2005.
DOI : 10.1128/JVI.79.14.9062-9068.2005

J. Goudsmit, W. Marissen, W. Weldon, M. Niezgoda, and C. Hanlon, Comparison of an Anti???Rabies Human Monoclonal Antibody Combination with Human Polyclonal Anti???Rabies Immune Globulin, The Journal of Infectious Diseases, vol.193, issue.6, pp.796-801, 2006.
DOI : 10.1086/500470

A. Bakker, C. Python, C. Kissling, P. Pandya, and W. Marissen, First administration to humans of a monoclonal antibody cocktail against rabies virus: Safety, tolerability, and neutralizing activity, Vaccine, vol.26, issue.47, pp.5922-5927, 2008.
DOI : 10.1016/j.vaccine.2008.08.050

J. Smith, P. Yager, and G. Baer, Anti-rabies Mouse Monoclonal Antibody Cocktail www.plosntds.org 30 A rapid reproducible test for determining rabies neutralizing antibodies, Bull World Health Org, vol.48, pp.535-541, 1973.

F. Cliquet, A. M. Sagné, and L. , Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody, Journal of Immunological Methods, vol.212, issue.1, pp.79-87, 1998.
DOI : 10.1016/S0022-1759(97)00212-3

L. Geue, S. Schares, C. Schnick, J. Kliemt, and A. Beckert, Genetic characterisation of attenuated SAD rabies virus strains used for oral vaccination of wildlife, Vaccine, vol.26, issue.26, pp.3227-3235, 2008.
DOI : 10.1016/j.vaccine.2008.04.007

URL : https://hal.archives-ouvertes.fr/pasteur-00365709

E. Desmézières, A. Maillard, Y. Gaudin, N. Tordo, and P. Perrin, Differential stability and fusion activity of Lyssavirus glycoprotein trimers, Virus Research, vol.91, issue.2, pp.181-187, 2003.
DOI : 10.1016/S0168-1702(02)00267-8

T. Nagarajan, G. Reddy, M. Subramanian, B. Rajalakshmi, S. Thiagarajan et al., A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture, Biologicals, vol.34, issue.1, pp.21-27, 2006.
DOI : 10.1016/j.biologicals.2005.07.004

L. Schneider, B. Barnard, H. Schneider, O. Odegaard, and J. Müller, Application of Monoclonal Antibodies for Epidemiological Investigations and Oral Vaccination Studies, Rabies in the Tropics, pp.47-59, 1985.
DOI : 10.1007/978-3-642-70060-6_6

B. Dietzschold, M. Tollis, M. Lafon, W. Wunner, and H. Koprowski, Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies, Virology, vol.161, issue.1, pp.29-36, 1987.
DOI : 10.1016/0042-6822(87)90167-X

J. Cox and L. Schneider, Prophylactic immunization of humans against rabies by intradermal inoculation of human diploid cell culture vaccine, J Clin Microbiol, vol.3, pp.96-101, 1976.

C. Hanlon, I. Kuzmin, J. Blanton, W. Weldon, and J. Manangan, Efficacy of rabies biologics against new lyssaviruses from Eurasia, Virus Research, vol.111, issue.1, pp.44-54, 2005.
DOI : 10.1016/j.virusres.2005.03.009

D. Dean, M. Abelseth, and P. Athanasiu, The fluorescence antibody test, Laboratory techniques in rabies. Geneva: World Health Organization, pp.88-93, 1996.

L. Olsson and H. Kaplan, Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity., Proceedings of the National Academy of Sciences, vol.77, issue.9, pp.5429-5431, 1980.
DOI : 10.1073/pnas.77.9.5429

K. Morimoto, M. Schnell, R. Pulmanausahakul, J. Mcgettigan, and H. Foley, High level expression of a human rabies virus-neutralizing monoclonal antibody by a rhabdovirus-based vector, Journal of Immunological Methods, vol.252, issue.1-2, pp.199-206, 2001.
DOI : 10.1016/S0022-1759(01)00353-2

M. Prosniak, M. Faber, C. Hanlon, C. Rupprecht, and D. Hooper, Development of a Cocktail of Recombinant???Expressed Human Rabies Virus???Neutralizing Monoclonal Antibodies for Postexposure Prophylaxis of Rabies, The Journal of Infectious Diseases, vol.188, issue.1, pp.53-56, 2003.
DOI : 10.1086/375247

S. Brookes, G. Parsons, N. Johnson, L. Mcelhinney, and A. Fooks, Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses, Vaccine, vol.23, issue.32, pp.4101-4109, 2005.
DOI : 10.1016/j.vaccine.2005.03.037

B. Dietzschold, T. Wiktor, W. Wunner, and A. Varrichio, Chemical and immunological analysis of the rabies soluble glycoprotein, Virology, vol.124, issue.2, pp.330-337, 1983.
DOI : 10.1016/0042-6822(83)90349-5

T. Wiktor, R. Macfarlan, C. Foggin, and H. Koprowski, Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies, Dev Biol Stand, vol.57, pp.199-211, 1984.

M. Lafon, L. Edelman, J. Bouvet, M. Lafage, and E. Montchâtre, Human Monoclonal Antibodies Specific for the Rabies Virus Glycoprotein and N Protein, Journal of General Virology, vol.71, issue.8, pp.1689-1696, 1990.
DOI : 10.1099/0022-1317-71-8-1689

J. Almagro and J. Fransson, Humanization of Antibodies, Front Biosci, vol.13, pp.1619-1633, 2008.
DOI : 10.1201/b15103-16

B. Dietzschold, C. Rupprecht, M. Tollis, M. Lafon, and J. Mattei, Antigenic Diversity of the Glycoprotein and Nucleocapsid Proteins of Rabies and Rabies-Related Viruses: Implications for Epidemiology and Control of Rabies, Clinical Infectious Diseases, vol.10, issue.Supplement 4, pp.785-798, 1988.
DOI : 10.1093/clinids/10.Supplement_4.S785